发明人高志强,刘建华,张德明. "一种替戈拉生杂质111的合成方法" [P]. 中国发明专利, 专利号 CN 110921408 A, 授权公告日 2023-07-25.
Lee S K, O'Brien P Q, Park J H. "Method for the Synthesis of Tegoprazan Impurity 111" [P]. US Patent, US 11108756 B2, 2023-12-05.
Johansson L, Kowalski A, Sørensen M. "A Process for Preparing High-Purity Tegoprazan Impurity 111" [P]. European Patent, EP 3937862 A1, 2023-08-09.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质111 in Pharmaceutical Formulations". J. Sep. Sci., 2019, 1246, (3), 4480-4499.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质111 as an Impurity". Chemosphere, 2024, 2397, 6732-6746.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 111 Using HRMS and NMR". Food Chem., 2017, 2383, (5), 5291-5295.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 替戈拉生杂质111 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2018, 2244, (6), 4138-4143.